INmune Bio Inc

General ticker "INMB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $99.9M

INmune Bio Inc does not follow the US Stock Market performance with the rate: -30.4%.

Estimated limits based on current volatility of 4.0%: low 4.32$, high 4.68$

Factors to consider:

  • Current price 29.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [6.46$, 14.85$]
  • 2024-12-30 to 2025-12-30 estimated range: [7.04$, 15.65$]

Financial Metrics affecting the INMB estimates:

  • Negative: Non-GAAP EPS, $ of -1.67 <= 0.10
  • Negative: Operating profit margin, % of -99.48 <= 1.03
  • Negative: Operating cash flow per share per price, % of -6.15 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term INMB quotes

Long-term INMB plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.18MM $0.37MM $0.15MM
Operating Expenses $29.33MM $26.32MM $29.90MM
Operating Income $-29.15MM $-25.95MM $-29.74MM
Non-Operating Income $-2.37MM $-2.70MM $-0.27MM
Interest Expense $0.00MM $1.35MM $0.00MM
R&D Expense $20.54MM $17.07MM $20.27MM
Income(Loss) $-31.53MM $-28.65MM $-30.01MM
Profit(Loss) $-31.53MM $-28.65MM $-30.01MM
Stockholders Equity $80.22MM $60.10MM $38.14MM
Assets $99.94MM $81.80MM $57.00MM
Operating Cash Flow $-28.50MM $-22.69MM $-11.98MM
Capital expenditure $15.00MM $0.00MM $0.00MM
Investing Cash Flow $-15.01MM $-0.70MM $0.00MM
Financing Cash Flow $96.36MM $0.73MM $-4.22MM
Earnings Per Share* $-1.88 $-1.60 $-1.67

* EPS are Split Adjusted, recent splits may be reflected with a delay.